Clinical Trial Update: The Role of HMGB-1 in Chronic Stroke

View source ↗

Summary

A clinical trial investigating HMGB-1 in chronic stroke, sponsored by Northwell Health, has been terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Stroke

Snippet

Sponsor: Northwell Health | Conditions: Cerebrovascular Accident, Cerebral Stroke | Status: TERMINATED